The global Liposome Drug Delivery revenue was US$ 3734 million in 2022 and is forecast to a readjusted size of US$ 8760.1 million by 2029 with a CAGR of 12.8% during the forecast period (2023-2029).

and India Liposome Drug Delivery Market

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

In India, the Liposome Drug Delivery revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

This report focuses on global and India Liposome Drug Delivery market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Liposome Drug Delivery will continue to grow rapidly in the future.

Global Liposome Drug Delivery Scope and Market Size

Liposome Drug Delivery market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Liposome Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Liposome Drug Delivery market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Liposome Drug Delivery Market Report

Report Metric	Details
Report Name	and India Liposome Drug Delivery Market
Forecasted market size in 2029	US$ 8760.1 million
CAGR	12.8%
Forecasted years	2023 - 2029
Segment by Type	Liposomal Doxorubicin Liposomal Amphoteracin B Liposomal Paclitaxel Others
Segment by Application	Fungal Infection Therapy Cancer & Tumor Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Liposome Drug Delivery Market size in 2029?

Ans: The and India Liposome Drug Delivery Market size in 2029 will be US$ 8760.1 million.

What is the market share of major companies in and India Liposome Drug Delivery Market?

Ans: Global top five manufacturers hold a share about 60%.

What is the and India Liposome Drug Delivery Market share by type?

Ans: In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%.

What is the and India Liposome Drug Delivery Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Liposome Drug Delivery Market report?

Ans: The main players in the and India Liposome Drug Delivery Market are Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang

What are the Application segmentation covered in the and India Liposome Drug Delivery Market report?

Ans: The Applications covered in the and India Liposome Drug Delivery Market report are Fungal Infection Therapy, Cancer & Tumor Therapy, Others

What are the Type segmentation covered in the and India Liposome Drug Delivery Market report?

Ans: The Types covered in the and India Liposome Drug Delivery Market report are Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

1 Study Coverage

1.1 Liposome Drug Delivery Product Introduction

1.2 Global Liposome Drug Delivery Outlook 2018 VS 2022 VS 2029

1.2.1 Global Liposome Drug Delivery Sales in US$ Million for the Year 2018-2029

1.2.2 Global Liposome Drug Delivery Sales in Volume for the Year 2018-2029

1.3 India Liposome Drug Delivery Outlook 2018 VS 2022 VS 2029

1.3.1 India Liposome Drug Delivery Sales in US$ Million for the Year 2018-2029

1.3.2 India Liposome Drug Delivery Sales in Volume for the Year 2018-2029

1.4 Liposome Drug Delivery Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Liposome Drug Delivery in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Liposome Drug Delivery Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Liposome Drug Delivery Market Dynamics

1.5.1 Liposome Drug Delivery Industry Trends

1.5.2 Liposome Drug Delivery Market Drivers

1.5.3 Liposome Drug Delivery Market Challenges

1.5.4 Liposome Drug Delivery Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Liposome Drug Delivery by Type

2.1 Liposome Drug Delivery Market Segment by Type

2.1.1 Liposomal Doxorubicin

2.1.2 Liposomal Amphoteracin B

2.1.3 Liposomal Paclitaxel

2.1.4 Others

2.2 Global Liposome Drug Delivery Market Size by Type

2.2.1 Global Liposome Drug Delivery Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Liposome Drug Delivery Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Liposome Drug Delivery Market Size by Type

2.3.1 India Liposome Drug Delivery Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Liposome Drug Delivery Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Liposome Drug Delivery by Application

3.1 Liposome Drug Delivery Market Segment by Application

3.1.1 Fungal Infection Therapy

3.1.2 Cancer & Tumor Therapy

3.1.3 Others

3.2 Global Liposome Drug Delivery Market Size by Application

3.2.1 Global Liposome Drug Delivery Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Liposome Drug Delivery Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Liposome Drug Delivery Market Size by Application

3.3.1 India Liposome Drug Delivery Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Liposome Drug Delivery Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Liposome Drug Delivery Competitor Landscape by Company

4.1 Global Liposome Drug Delivery Market Size by Company

4.1.1 Global Key Manufacturers of Liposome Drug Delivery, Ranked by Revenue (2022)

4.1.2 Global Liposome Drug Delivery Revenue by Manufacturer (2018-2023)

4.1.3 Global Liposome Drug Delivery Sales by Manufacturer (2018-2023)

4.1.4 Global Liposome Drug Delivery Price by Manufacturer (2018-2023)

4.2 Global Liposome Drug Delivery Concentration Ratio (CR)

4.2.1 Liposome Drug Delivery Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Liposome Drug Delivery in 2022

4.2.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Liposome Drug Delivery, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Liposome Drug Delivery, Product Offered and Application

4.5 Global Key Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Liposome Drug Delivery Market Size by Company

4.7.1 Key Players of Liposome Drug Delivery in India, Ranked by Revenue (2022)

4.7.2 India Liposome Drug Delivery Revenue by Players (2018-2023)

4.7.3 India Liposome Drug Delivery Sales by Players (2018-2023)

5 Global Liposome Drug Delivery Market Size by Region

5.1 Global Liposome Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Liposome Drug Delivery Market Size in Volume by Region (2018-2029)

5.2.1 Global Liposome Drug Delivery Sales in Volume by Region: 2018-2023

5.2.2 Global Liposome Drug Delivery Sales in Volume Forecast by Region (2024-2029)

5.3 Global Liposome Drug Delivery Market Size in Value by Region (2018-2029)

5.3.1 Global Liposome Drug Delivery Sales in Value by Region: 2018-2023

5.3.2 Global Liposome Drug Delivery Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Liposome Drug Delivery Market Size YoY Growth 2018-2029

6.2 Americas Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Liposome Drug Delivery Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Liposome Drug Delivery Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Liposome Drug Delivery Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Liposome Drug Delivery Market Size YoY Growth 2018-2029

7.2 EMEA Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Liposome Drug Delivery Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Liposome Drug Delivery Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Liposome Drug Delivery Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Liposome Drug Delivery Market Size YoY Growth 2018-2029

8.2 China Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Liposome Drug Delivery Market Size YoY Growth 2018-2029

9.2 APAC Liposome Drug Delivery Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Liposome Drug Delivery Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Liposome Drug Delivery Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Liposome Drug Delivery Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Liposome Drug Delivery Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Gilead Sciences

10.1.1 Gilead Sciences Company Information

10.1.2 Gilead Sciences Description and Business Overview

10.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Gilead Sciences Liposome Drug Delivery Products Offered

10.1.5 Gilead Sciences Recent Development

10.2 Pacira

10.2.1 Pacira Company Information

10.2.2 Pacira Description and Business Overview

10.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Pacira Liposome Drug Delivery Products Offered

10.2.5 Pacira Recent Development

10.3 Sun Pharmaceutical

10.3.1 Sun Pharmaceutical Company Information

10.3.2 Sun Pharmaceutical Description and Business Overview

10.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Sun Pharmaceutical Liposome Drug Delivery Products Offered

10.3.5 Sun Pharmaceutical Recent Development

10.4 Johnson & Johnson

10.4.1 Johnson & Johnson Company Information

10.4.2 Johnson & Johnson Description and Business Overview

10.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Johnson & Johnson Liposome Drug Delivery Products Offered

10.4.5 Johnson & Johnson Recent Development

10.5 Luye Pharma

10.5.1 Luye Pharma Company Information

10.5.2 Luye Pharma Description and Business Overview

10.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Luye Pharma Liposome Drug Delivery Products Offered

10.5.5 Luye Pharma Recent Development

10.6 Sigma-Tau

10.6.1 Sigma-Tau Company Information

10.6.2 Sigma-Tau Description and Business Overview

10.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Sigma-Tau Liposome Drug Delivery Products Offered

10.6.5 Sigma-Tau Recent Development

10.7 Ipsen (Onivyde)

10.7.1 Ipsen (Onivyde) Company Information

10.7.2 Ipsen (Onivyde) Description and Business Overview

10.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Ipsen (Onivyde) Liposome Drug Delivery Products Offered

10.7.5 Ipsen (Onivyde) Recent Development

10.8 CSPC

10.8.1 CSPC Company Information

10.8.2 CSPC Description and Business Overview

10.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.8.4 CSPC Liposome Drug Delivery Products Offered

10.8.5 CSPC Recent Development

10.9 Teva Pharmaceutical

10.9.1 Teva Pharmaceutical Company Information

10.9.2 Teva Pharmaceutical Description and Business Overview

10.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Teva Pharmaceutical Liposome Drug Delivery Products Offered

10.9.5 Teva Pharmaceutical Recent Development

10.10 Novartis

10.10.1 Novartis Company Information

10.10.2 Novartis Description and Business Overview

10.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Novartis Liposome Drug Delivery Products Offered

10.10.5 Novartis Recent Development

10.11 Fudan-Zhangjiang

10.11.1 Fudan-Zhangjiang Company Information

10.11.2 Fudan-Zhangjiang Description and Business Overview

10.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Fudan-Zhangjiang Liposome Drug Delivery Products Offered

10.11.5 Fudan-Zhangjiang Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Liposome Drug Delivery Industry Chain Analysis

11.2 Liposome Drug Delivery Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Liposome Drug Delivery Production Mode & Process

11.4 Liposome Drug Delivery Sales and Marketing

11.4.1 Liposome Drug Delivery Sales Channels

11.4.2 Liposome Drug Delivery Distributors

11.5 Liposome Drug Delivery Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Liposome Drug Delivery CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Liposome Drug Delivery Market Trends

Table 3. Liposome Drug Delivery Market Drivers

Table 4. Liposome Drug Delivery Market Challenges

Table 5. Liposome Drug Delivery Market Restraints

Table 6. Global Liposome Drug Delivery Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Liposome Drug Delivery Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Liposome Drug Delivery Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Liposome Drug Delivery Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Liposome Drug Delivery, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Liposome Drug Delivery Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Liposome Drug Delivery Revenue Share by Manufacturer, 2018-2023

Table 13. Global Liposome Drug Delivery Sales by Manufacturer, (K Vial), 2018-2023

Table 14. Global Liposome Drug Delivery Sales Share by Manufacturer, 2018-2023

Table 15. Global Liposome Drug Delivery Price by Manufacturer (2018-2023) & (USD/Vial)

Table 16. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2022)

Table 18. Global Key Manufacturers of Liposome Drug Delivery, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Liposome Drug Delivery, Product Offered and Application

Table 20. Global Key Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Liposome Drug Delivery in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Liposome Drug Delivery Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Liposome Drug Delivery Revenue Share by Players, (2018-2023)

Table 25. India Liposome Drug Delivery Sales by Players, (K Vial), (2018-2023)

Table 26. India Liposome Drug Delivery Sales Share by Players, (2018-2023)

Table 27. Global Liposome Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Liposome Drug Delivery Sales in Volume by Region (2018-2023) & (K Vial)

Table 29. Global Liposome Drug Delivery Sales in Volume Forecast by Region (2024-2029) & (K Vial)

Table 30. Global Liposome Drug Delivery Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Liposome Drug Delivery Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Liposome Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Liposome Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Liposome Drug Delivery Sales in Volume by Country (2018-2023) & (K Vial)

Table 36. Americas Liposome Drug Delivery Sales in Volume by Country (2024-2029) & (K Vial)

Table 37. EMEA Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Liposome Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Liposome Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Liposome Drug Delivery Sales in Volume by Country (2018-2023) & (K Vial)

Table 41. EMEA Liposome Drug Delivery Sales in Volume by Country (2024-2029) & (K Vial)

Table 42. APAC Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Liposome Drug Delivery Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Liposome Drug Delivery Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Liposome Drug Delivery Sales in Volume by Country (2018-2023) & (K Vial)

Table 46. APAC Liposome Drug Delivery Sales in Volume by Country (2024-2029) & (K Vial)

Table 47. Gilead Sciences Company Information

Table 48. Gilead Sciences Description and Business Overview

Table 49. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 50. Gilead Sciences Liposome Drug Delivery Product

Table 51. Gilead Sciences Recent Development

Table 52. Pacira Company Information

Table 53. Pacira Description and Business Overview

Table 54. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 55. Pacira Liposome Drug Delivery Product

Table 56. Pacira Recent Development

Table 57. Sun Pharmaceutical Company Information

Table 58. Sun Pharmaceutical Description and Business Overview

Table 59. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 60. Sun Pharmaceutical Liposome Drug Delivery Product

Table 61. Sun Pharmaceutical Recent Development

Table 62. Johnson & Johnson Company Information

Table 63. Johnson & Johnson Description and Business Overview

Table 64. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 65. Johnson & Johnson Liposome Drug Delivery Product

Table 66. Johnson & Johnson Recent Development

Table 67. Luye Pharma Company Information

Table 68. Luye Pharma Description and Business Overview

Table 69. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 70. Luye Pharma Liposome Drug Delivery Product

Table 71. Luye Pharma Recent Development

Table 72. Sigma-Tau Company Information

Table 73. Sigma-Tau Description and Business Overview

Table 74. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 75. Sigma-Tau Liposome Drug Delivery Product

Table 76. Sigma-Tau Recent Development

Table 77. Ipsen (Onivyde) Company Information

Table 78. Ipsen (Onivyde) Description and Business Overview

Table 79. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 80. Ipsen (Onivyde) Liposome Drug Delivery Product

Table 81. Ipsen (Onivyde) Recent Development

Table 82. CSPC Company Information

Table 83. CSPC Description and Business Overview

Table 84. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 85. CSPC Liposome Drug Delivery Product

Table 86. CSPC Recent Development

Table 87. Teva Pharmaceutical Company Information

Table 88. Teva Pharmaceutical Description and Business Overview

Table 89. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 90. Teva Pharmaceutical Liposome Drug Delivery Product

Table 91. Teva Pharmaceutical Recent Development

Table 92. Novartis Company Information

Table 93. Novartis Description and Business Overview

Table 94. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 95. Novartis Liposome Drug Delivery Product

Table 96. Novartis Recent Development

Table 97. Fudan-Zhangjiang Company Information

Table 98. Fudan-Zhangjiang Description and Business Overview

Table 99. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)

Table 100. Fudan-Zhangjiang Liposome Drug Delivery Product

Table 101. Fudan-Zhangjiang Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Liposome Drug Delivery Customers List

Table 105. Liposome Drug Delivery Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Liposome Drug Delivery Product Picture

Figure 2. Global Liposome Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Liposome Drug Delivery Market Size 2018-2029 (US$ Million)

Figure 4. Global Liposome Drug Delivery Sales 2018-2029 (K Vial)

Figure 5. India Liposome Drug Delivery Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Liposome Drug Delivery Market Size 2018-2029 (US$ Million)

Figure 7. India Liposome Drug Delivery Sales 2018-2029 (K Vial)

Figure 8. India Liposome Drug Delivery Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Liposome Drug Delivery Market Share in Global, in Volume (K Vial) 2018-2029

Figure 10. Liposome Drug Delivery Report Years Considered

Figure 11. Product Picture of Liposomal Doxorubicin

Figure 12. Product Picture of Liposomal Amphoteracin B

Figure 13. Product Picture of Liposomal Paclitaxel

Figure 14. Product Picture of Others

Figure 15. Global Liposome Drug Delivery Market Share by Type in 2022 & 2029

Figure 16. Global Liposome Drug Delivery Sales in Value by Type (2018-2029) & (US$ Million)

Figure 17. Global Liposome Drug Delivery Sales Market Share in Value by Type (2018-2029)

Figure 18. Global Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 19. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 20. Global Liposome Drug Delivery Price by Type (2018-2029) & (USD/Vial)

Figure 21. India Liposome Drug Delivery Market Share by Type in 2022 & 2029

Figure 22. India Liposome Drug Delivery Sales in Value by Type (2018-2029) & (US$ Million)

Figure 23. India Liposome Drug Delivery Sales Market Share in Value by Type (2018-2029)

Figure 24. India Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 25. India Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 26. India Liposome Drug Delivery Price by Type (2018-2029) & (USD/Vial)

Figure 27. Product Picture of Fungal Infection Therapy

Figure 28. Product Picture of Cancer & Tumor Therapy

Figure 29. Product Picture of Others

Figure 30. Global Liposome Drug Delivery Market Share by Application in 2022 & 2029

Figure 31. Global Liposome Drug Delivery Sales in Value by Application (2018-2029) & (US$ Million)

Figure 32. Global Liposome Drug Delivery Sales Market Share in Value by Application (2018-2029)

Figure 33. Global Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 34. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 35. Global Liposome Drug Delivery Price by Application (2018-2029) & (USD/Vial)

Figure 36. India Liposome Drug Delivery Market Share by Application in 2022 & 2029

Figure 37. India Liposome Drug Delivery Sales in Value by Application (2018-2029) & (US$ Million)

Figure 38. India Liposome Drug Delivery Sales Market Share in Value by Application (2018-2029)

Figure 39. India Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 40. India Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 41. India Liposome Drug Delivery Price by Application (2018-2029) & (USD/Vial)

Figure 42. Americas Liposome Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vial)

Figure 43. Americas Liposome Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 44. Americas Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 45. Americas Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 46. Americas Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 47. Americas Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 48. United States Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Canada Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. Mexico Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. Brazil Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 52. EMEA Liposome Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vial)

Figure 53. EMEA Liposome Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 54. EMEA Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 55. EMEA Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 56. EMEA Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 57. EMEA Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 58. Europe Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. Middle East Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 60. Africa Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 61. China Liposome Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vial)

Figure 62. China Liposome Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 63. China Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 64. China Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 65. China Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 66. China Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 67. APAC Liposome Drug Delivery Sales in Volume Growth Rate 2018-2029 (K Vial)

Figure 68. APAC Liposome Drug Delivery Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 69. APAC Liposome Drug Delivery Sales by Type (2018-2029) & (K Vial)

Figure 70. APAC Liposome Drug Delivery Sales Market Share in Volume by Type (2018-2029)

Figure 71. APAC Liposome Drug Delivery Sales by Application (2018-2029) & (K Vial)

Figure 72. APAC Liposome Drug Delivery Sales Market Share in Volume by Application (2018-2029)

Figure 73. Japan Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. South Korea Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. China Taiwan Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. Southeast Asia Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. India Liposome Drug Delivery Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 78. Liposome Drug Delivery Value Chain

Figure 79. Liposome Drug Delivery Production Process

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles

Figure 82. Bottom-up and Top-down Approaches for This Report

Figure 83. Data Triangulation

Figure 84. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions